Protocol-directed prostate cancer active surveillance offers acceptable oncologic safety. Protocol-directed active surveillance of localized prostate cancer reduces unnecessary treatment of men ...

Confirmatory or systematic prostate biopsies may be unnecessary for men considering active surveillance for prostate cancer who have negative findings on multiparametric MRI scans. Multiparametric MRI ...

Half of men with low-risk prostate cancer remained free from progression or treatment 10 years after diagnosis when followed in a protocol-directed active surveillance program. At 10 years, 43% of ...

Results from the Canary PASS study show good health outcomes among patients taking part in active surveillance over nearly 10 years of follow-up. Prostate cancer is frequently slow-growing, leading to ...

About The Study: In this study, 10 years after diagnosis, 49% of men remained free of progression or treatment, less than 2% developed metastatic disease, and less than 1% died of their disease. Later ...

Please provide your email address to receive an email when new articles are posted on . Results refute criticisms about “losing a window of curability when delaying treatment.” Researchers estimated ...

If your cancer is not causing any symptoms, is growing slowly, or is small and only in your prostate, your physician may suggest active surveillance or watchful waiting instead of treatment. Active ...

SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced today an update to the ArteraAI Prostate Test ...

What key experiences or clinical gaps motivated your focus on advancing prostate cancer diagnostics, particularly MRI-led ...

Prostate cancer is the most common solid malignancy among men in the United States. According to the American Cancer Society, an estimated 313,780 men nationwide will be diagnosed with the disease in ...